EUVIMEDEUVIMED entdecken
Crossref

Patient experiences with clinical confirmatory genetic testing after using direct-to-consumer raw DNA and third-party genetic interpretation services

Tiffany T Nguyen Dolphyn iD, Kelly E Ormond iD, Scott M Weissman, Helen J Kim, Chloe M Reuter iD

Translational Behavioral Medicine · 2023

DOI: 10.1093/tbm/ibac083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Behavioral Medicine, 2023. Verfasst von Tiffany T Nguyen Dolphyn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Stanford School of Medicine, Stanford University, Stanford, California, 94305USA. Hauptthemen laut MEDLINE: Direct-To-Consumer Screening and Testing, Social Media. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Society of Genetic Counselors.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The availability of raw DNA and genetic interpretation tools allow individuals to access genetic health risk information, where analytical false-positives exist. Little is known about the experience of individuals who receive pathogenic or likely pathogenic variant(s) through raw DNA interpretation and follow-up with clinical confirmatory genetic testing. This qualitative study set out to describe the experiences of individuals who pursued clinical confirmatory genetic testing, including their perception of the process. Participants were recruited from social media and eligible if they discovered a potential pathogenic or likely pathogenic variant in a raw DNA interpretation report, completed clinical confirmatory genetic testing in the U.S., and provided documentation of those results. Individuals participated in semi-structured interviews, which were transcribed and inductively coded to identify themes. Of the 12 participants, 3 received clinical genetic testing results that confirmed pathogenic or likely pathogenic variants noted in raw DNA interpretation reports (confirmation positive), and 9 were not confirmed. Nearly all (n = 11) participants described emotional distress and information-seeking behavior as a coping mechanism after discovering a pathogenic or likely pathogenic variant in raw DNA interpretation. When pursuing confirmatory genetic testing, many (n = 9) faced challenges with finding knowledgeable healthcare providers and obtaining insurance coverage. Despite reporting concerns over raw DNA interpretation and a desire for more safeguards, almost all (n = 10) participants stated interest in using the service again. Overall, participants’ experiences reveal they find personal utility in raw DNA interpretation results and provide insight into opportunities for patient and provider education.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Direct-To-Consumer Screening and TestingSocial MediaHumansGenetic TestingDNAPatient Outcome Assessment

Stichwörter der Autor:innen

Direct-to-consumerGenetic testingPersonal utilityPrecision medicineRaw DNAThird-party interpretation

Substanzen

DNA

Autor:innen und Institutionen

  • Department of Genetics, Stanford School of Medicine, Stanford University, Stanford, California, 94305USA.
  • Stanford Medicine Clinical Genomics Program, Stanford School of Medicine, Stanford University, Stanford, California, 94305, USA.
  • Department of Genetics and Stanford Center for Biomedical Ethics, Stanford School of Medicine, Stanford University, Stanford, California, 94305, USA.
  • Health Ethics and Policy Lab, Department of Health Science and Technology, ETH Zurich, 8092 Zurich, Switzerland.
  • Chicago Genetic Consultants, Northbrook, Illinois, 60062, USA.
  • Stanford Center for Inherited Cardiovascular Disease, Stanford Health Care, Stanford, California, 94305, USA.

ORCID-Profile: Tiffany T Nguyen Dolphyn, Kelly E Ormond, Chloe M Reuter

Förderung

  • National Society of Genetic Counselors

Zitieren

APA

Nguyen Dolphyn, T. T., Ormond, K. E., Weissman, S. M., Kim, H. J., & Reuter, C. M. (2023). Patient experiences with clinical confirmatory genetic testing after using direct-to-consumer raw DNA and third-party genetic interpretation services. Translational Behavioral Medicine. https://doi.org/10.1093/tbm/ibac083

Vancouver

Nguyen Dolphyn TT, Ormond KE, Weissman SM, Kim HJ, Reuter CM. Patient experiences with clinical confirmatory genetic testing after using direct-to-consumer raw DNA and third-party genetic interpretation services. Translational Behavioral Medicine. 2023. doi:10.1093/tbm/ibac083

BibTeX
@article{NguyenDolphyn2023,
  author = {Nguyen Dolphyn, Tiffany T and Ormond, Kelly E and Weissman, Scott M and Kim, Helen J and Reuter, Chloe M},
  title = {Patient experiences with clinical confirmatory genetic testing after using direct-to-consumer raw DNA and third-party genetic interpretation services},
  journal = {Translational Behavioral Medicine},
  year = {2023},
  doi = {10.1093/tbm/ibac083}
}
Kostenlos starten →